rethinkPeptides Search
Menu
Research citation

Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.

The lancet. Gastroenterology & hepatology, 8(2), 179-191

Citation

Targher, Giovanni; Mantovani, Alessandro; Byrne, Christopher D. (2023). Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.. The lancet. Gastroenterology & hepatology, 8(2), 179-191. https://doi.org/10.1016/S2468-1253(22)00338-7